An ongoing study of key immune system proteins has pinpointed an area associated with increased risk for inflammatory disease and may one day lead to new therapies to control inflammation and rheumatic diseases.
New Approaches to Inflammatory Myopathy
Advances in diagnostic modalities and treatments emerge
Family, Fatigue & Heart Health
Researchers explore several factors in the health and well-being of patients with lupus
Chronotherapy with Glucorticoids in Rheumatoid Arthritis
Time is of the essence in balancing risks and benefits
New ACR and ARHP Leaders Join the Ranks
The ACR is pleased to welcome new and returning leaders to the ACR board of directors and ARHP executive committee who were appointed in November. The following members were selected to serve as the newest members-at-large of the ACR board of directors. Each of them shared what they will bring to the table.
A Review of Wegener’s Treatment Data
Clinical trials show changing role of existing treatment and introduction of newer medications
Drug UPDATES
Information on New Approvals and Medication Safety
Shingles, Chickenpox Hospitalizations Higher for Patients on Anti-TNF Drugs
More research needed to clarify risks and benefits of VZV vaccination
Can Technology Help Solve Scleroderma Renal Crisis?
A case study in using the Internet to facilitate rare disease research
ACR Honors Accomplishments in Rheumatology
Rheumatologists and health professionals recognized for their contributions to the field
- « Previous Page
- 1
- …
- 62
- 63
- 64
- 65
- 66
- …
- 76
- Next Page »